June 11, 2014

More than 29 million people in the United States have diabetes, up from the previous estimate of 26 million in 2010, according to a report released Tuesday by the Centers for Disease Control and Prevention.

June 11, 2014

Strativa Pharmaceutical, a division of Par Pharmaceutical Cos., announced that the Food and Drug Administration approved Nascobal, a prescription B-12 supplement administered once a week as one spray.

June 11, 2014

QS/1, a complete healthcare automation solutions provider, on Tuesday announced it is partnering with VUCA Health to offer on-demand prescription-specific videos, as well as other services to engage patients and strengthen customer relationships.

June 11, 2014

The National Center for Health Statistics released a report finding that married men were more likely than not-married men to have had a healthcare visit within the past 12 months.

June 11, 2014

The West Virginia Retailers Association on Tuesday issued testimony that the National Precursor Log Exchange (NPLEx) works in curbing the diversion of pseudoephedrine into methemphetamine.

June 10, 2014

Canada’s Federal court ruled recently that the country’s Patented Medicine Prices Review Board – a federal tribunal that regulates pricing on branded medicines – could not extend price control measures to cover generic drug companies.

June 10, 2014

The Food and Drug Administration last week published an interim final rule to further safeguard the health of infants fed infant formula in the United States.

June 10, 2014

New York Gov. Andrew Cuomo last week announced an agreement between New York State and GW Pharmaceuticals to develop clinical trials using an active ingredient derived from the marijuana plant to help treat children diagnosed with epilepsy who suffer from seizures and other medical complications.

June 10, 2014

Ohio Gov. John Kasich on Monday signed executive order 2014-04K authorizing licensed pharmacists to administer the measles, mumps, and rubella (MMR) vaccine to individuals 18 years and older in order to provide those adults who have not yet received this vaccination with additional opportunities to obtain the MMR vaccine.

June 9, 2014

Dr. Robynne Chutkan is the founder of the Digestive Center for Women, an integrative gastroenterology practice in Chevy Chase, Maryland. She’s on the faculty at Georgetown Hospital, a former board member of the American Society for Gastrointestinal Endoscopy (ASGE), and the author of “Gutbliss: A 10-Day Plan to Ban Bloat, Flush Toxins, and Dump Your Digestive Baggage.”

June 9, 2014

BioDelivery Sciences International on Monday announced that the Food and Drug Administration approved its new drug application for Bunavail (buprenorphine and naloxone) buccal film (CIII).

June 9, 2014

Teva on Monday announced that the Food and Drug Administration approved an expanded label for Azilect (rasagiline tablets) from monotherapy and adjunct to levodopa to now include dopamine agonists.

June 9, 2014

A recently approved drug might make infusions for hemophiliacs fewer and further between. The Food and Drug Administration approved Biogen Idec's Eloctate, which clinical trials have shown works to treat bleeding episodes and to increase the time between prophylactic blood infusions for those with hemophilia A.

June 9, 2014

The Office of the National Coordinator for Health Information Technology last week issued a policy paper, "A 10-Year Vision to Achieve an Interoperable Health IT Infrastructure," which outlines the government's pledge to support interoperable electronic health records to most Americans.

June 9, 2014

A report published Friday in the Morbidity and Mortality Weekly Report characterized the 2013-2014 influenza season as the first season since 2009 that H1N1 generated fewer levels of outpatient illness and mortality as compared with seasons when influenza A (H3N2) is predominant.

June 9, 2014

Mylan on Monday announced the launch of carboplatin injection, 50-mg/5-ml, in multi-dose vials. The drug is the generic version of Paraplatin injection from Bristol-Myers Squibb.

June 9, 2014

As healthcare decision-makers grapple with how to ensure access to specialty medications, the University of Michigan Center for Value-Based Insurance Design and the National Pharmaceutical Council on Monday released a new report, "Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design," which explores how value-based insurance design could be utilized to address specialty medication access concerns.

June 9, 2014

Strides Arcolab last week received approval from the Food and Drug Administration for methoxsalen capsules USP, 10-mg (soft gelatin capsules).

June 6, 2014

The Senate confirmed former Walmart executive Sylvia Burwell as Secretary of the Department of Health and Human Services on Thursday by a vote of 78-17, according to several reports.

June 6, 2014

Teva Pharmaceuticals announced the launch of Mimvey Lo (estradiol and norethindrone acetate tablets, USP), the generic equivalent to Activella tablets.

June 6, 2014

Upsher-Smith Laboratories on Wednesday announced that it has received final approval from the Food and Drug Administration for its new drug application for Vogelxo (testosterone) gel for topical use CIII.

June 5, 2014

McKesson Pharmacy Systems and Automation has launched a pilot program to test its Adherence Performance reporting solution and provide pharmacies with an adherence rating similar to the CMS Star Ratings provided to health plans.

June 5, 2014

Low-risk patients were three times less likely to be admitted to a hospital when they received medication therapy management from a pharmacist, according to the findings of a recent study that was highlighted in Forbes magazine.

June 4, 2014

Cardinal Health on Wednesday launched a new solution to make it easier and more time-efficient for retail pharmacies to help patients better understand and adhere to their medications.